Works about ALENDRONATE
Results: 889
Medication-Related Osteonecrosis of the Jaw Subsequent to Peri-Implantitis: A Case Report and Literature Review.
- Published in:
- Journal of Oral Implantology, 2021, v. 47, n. 6, p. 502, doi. 10.1563/aaid-joi-D-19-00385
- By:
- Publication type:
- Article
Osteoporosis.
- Published in:
- Current Medical Literature: Rheumatology, 2011, v. 30, n. 4, p. 141
- Publication type:
- Article
Osteoporosis Management.
- Published in:
- Journal of Women's Health (15409996), 2020, v. 29, n. 3, p. 287, doi. 10.1089/jwh.2019.8195
- By:
- Publication type:
- Article
Phosphate group vibrational signatures of the osteoporosis drug alendronate.
- Published in:
- Journal of Raman Spectroscopy, 2014, v. 45, n. 9, p. 801, doi. 10.1002/jrs.4559
- By:
- Publication type:
- Article
Retraction Note: Comparison of the effect of alendronate on lumbar bone mineral density and bone turnover in men and postmenopausal women with osteoporosis.
- Published in:
- Clinical Rheumatology, 2021, v. 40, n. 8, p. 3385, doi. 10.1007/s10067-021-05788-3
- By:
- Publication type:
- Article
Editorial Expression of Concern: Experience with alendronate treatment for 7 years among Japanese men with osteoporosis or osteopenia and clinical risk factors for fractures.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Combined pharmacotherapy for osteonecrosis of the femoral head after severe acute respiratory syndrome and interstitial pneumonia: two and a half to fourteen year follow-up.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Effects of drug discontinuation after short-term daily alendronate administration on osteoblasts and osteocytes in mice.
- Published in:
- Histochemistry & Cell Biology, 2016, v. 146, n. 3, p. 337, doi. 10.1007/s00418-016-1450-7
- By:
- Publication type:
- Article
Influence of pH on osteoclasts treated with zoledronate and alendronate.
- Published in:
- Clinical Oral Investigations, 2019, v. 23, n. 2, p. 813, doi. 10.1007/s00784-018-2505-z
- By:
- Publication type:
- Article
Effects of an oral bisphosphonate and three intravenous bisphosphonates on several cell types in vitro.
- Published in:
- Clinical Oral Investigations, 2018, v. 22, n. 7, p. 2527, doi. 10.1007/s00784-018-2349-6
- By:
- Publication type:
- Article
Prolonged use of alendronate alters the biology of cranial repair in estrogen-deficient rats’ associated simultaneous immunohistochemical expression of TGF-β1+, α-ER+, and BMPR1B-.
- Published in:
- Clinical Oral Investigations, 2018, v. 22, n. 5, p. 1959, doi. 10.1007/s00784-017-2292-y
- By:
- Publication type:
- Article
Bisphosphonates hinder osteoblastic/osteoclastic differentiation in the maxillary sinus mucosa-derived stem cells.
- Published in:
- Clinical Oral Investigations, 2018, v. 22, n. 5, p. 1933, doi. 10.1007/s00784-017-2291-z
- By:
- Publication type:
- Article
Raloxifene but not alendronate can compensate the impaired osseointegration in osteoporotic rats.
- Published in:
- Clinical Oral Investigations, 2018, v. 22, n. 1, p. 255, doi. 10.1007/s00784-017-2106-2
- By:
- Publication type:
- Article
Immunoexpression of IGF1, IGF2, and osteopontin in craniofacial bone repair associated with autogenous grafting in rat models treated with alendronate sodium.
- Published in:
- Clinical Oral Investigations, 2017, v. 21, n. 5, p. 1895, doi. 10.1007/s00784-016-1975-0
- By:
- Publication type:
- Article
Effect of alendronate on the progression of periodontitis induced by Porphyromonas gingivalis and Fusobacterium nucleatum: a study in rats.
- Published in:
- Clinical Oral Investigations, 2016, v. 20, n. 9, p. 2565, doi. 10.1007/s00784-016-1769-4
- By:
- Publication type:
- Article
Altered macrophagic THP-1 cell phagocytosis and migration in bisphosphonate-related osteonecrosis of the jaw (BRONJ).
- Published in:
- Clinical Oral Investigations, 2016, v. 20, n. 5, p. 1043, doi. 10.1007/s00784-015-1584-3
- By:
- Publication type:
- Article
Changes in Serum Levels of Cartilage Oligomeric Matrix Protein after Estrogen and Alendronate Therapy in Postmenopausal Women.
- Published in:
- Gynecologic & Obstetric Investigation, 2012, v. 74, n. 2, p. 143, doi. 10.1159/000339934
- By:
- Publication type:
- Article
Changes in Serum Levels of Cartilage Oligomeric Matrix Protein after Estrogen and Alendronate Therapy in Postmenopausal Women.
- Published in:
- Gynecologic & Obstetric Investigation, 2012, v. 74, n. 2, p. 143, doi. 10.1159/000339934
- By:
- Publication type:
- Article
Bilateral Simultaneous Atypical Femoral Fracture: A Case Report.
- Published in:
- Case Reports in Clinical Practice, 2022, v. 7, n. 2, p. 68
- By:
- Publication type:
- Article
Site-activatable targeting of macromolecular alendronate for accelerated fracture healing.
- Published in:
- Science & Technology of Advanced Materials, 2023, v. 24, n. 1, p. 1, doi. 10.1080/14686996.2023.2286218
- By:
- Publication type:
- Article
مقبيسه اثر تجويس النذرونت بب پبميذرونت در وضعيت تراكم استخوان بيمبران مبتلا به استئوپروز
- Published in:
- Journal of Birjand University of Medical Sciences, 2018, v. 25, n. 4, p. 307
- By:
- Publication type:
- Article
KINETIC MODELLING OF ALENDRONATE FUNCTIONALISED CHITOSAN NANOPARTICLES - DEVELOPMENT TO in vitro RELEASE STUDY.
- Published in:
- Oxidation Communications, 2022, v. 45, n. 1, p. 103
- By:
- Publication type:
- Article
The ExcellMater project for advancements in biomaterials and 3D in vitro culture systems for applications in pharmacy and biomedicine.
- Published in:
- Macedonian Pharmaceutical Bulletin / Makedonsko Farmacevtski Bilten, 2023, v. 69, p. 5, doi. 10.33320/maced.pharm.bull.2023.69.03.002
- By:
- Publication type:
- Article
EFFECTS OF SHORT TERM ALENDRONATE ADMINISTRATION ON BONE MINERAL DENSITY IN PATIENTS WITH CHRONIC KIDNEY DISEASE.
- Published in:
- Contributions / Prilozi (1857-9345), 2018, v. 39, n. 1, p. 5, doi. 10.2478/prilozi-2018-0019
- By:
- Publication type:
- Article
Effects of silk fibroin hydrolysate on bone metabolism in ovariectomized rats.
- Published in:
- International Journal of Industrial Entomology & Biomaterials, 2015, v. 30, n. 1, p. 17, doi. 10.7852/ijie.2015.30.1.17
- By:
- Publication type:
- Article
Ameliorative Role of Lactoferrin on Osteoporosis Caused by Glucocorticoids.
- Published in:
- Egyptian Academic Journal of Biological Sciences. B, Zoology, 2019, v. 11, n. 1, p. 65
- By:
- Publication type:
- Article
Hypervitaminosis D Due to Overdose: A Case Series.
- Published in:
- Indian Journal of Pain, 2024, v. 38, n. 2, p. 153, doi. 10.4103/ijpn.ijpn_89_23
- By:
- Publication type:
- Article
Effects of Alendronate on Lumbar Posterolateral Fusion Using Hydroxyapatite in Rabbits.
- Published in:
- Artificial Organs, 2012, v. 36, n. 12, p. 1047, doi. 10.1111/j.1525-1594.2012.01509.x
- By:
- Publication type:
- Article
Alendronate-Grafted Nanoemulsions for Bone-Targeted Vincristine Delivery: Preliminary Studies on Cell and Animal Models.
- Published in:
- Biomolecules (2218-273X), 2024, v. 14, n. 2, p. 238, doi. 10.3390/biom14020238
- By:
- Publication type:
- Article
Pegylated Liposomal Alendronate Biodistribution, Immune Modulation, and Tumor Growth Inhibition in a Murine Melanoma Model.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 9, p. 1309, doi. 10.3390/biom13091309
- By:
- Publication type:
- Article
Does Routine Anti-Osteoporosis Medication Lower the Risk of Fractures in Male Subjects? An Updated Systematic Review With Meta-Analysis of Clinical Trials.
- Published in:
- Frontiers in Pharmacology, 2019, p. 1, doi. 10.3389/fphar.2019.00882
- By:
- Publication type:
- Article
How does alendronate affect orthodontic tooth movement in osteogenesis imperfecta: an in vivo study on a mice model.
- Published in:
- European Journal of Orthodontics, 2023, v. 45, n. 2, p. 217, doi. 10.1093/ejo/cjad001
- By:
- Publication type:
- Article
Cost-Effectiveness of Sequential Abaloparatide/Alendronate in Men at High Risk of Fractures in the United States.
- Published in:
- PharmacoEconomics, 2023, v. 41, n. 7, p. 819, doi. 10.1007/s40273-023-01270-x
- By:
- Publication type:
- Article
Quality of life of postmenopausal women with teriparatide, denosumab and alendronate: One-year prospective study with a propensity score-matched comparison.
- Published in:
- Journal of Orthopaedics, Trauma & Rehabilitation, 2023, v. 30, n. 1, p. 1, doi. 10.1177/22104917221136282
- By:
- Publication type:
- Article
Editorial: Diabetes and bone - from cell to human.
- Published in:
- Frontiers in Endocrinology, 2022, v. 13, p. 1, doi. 10.3389/fendo.2022.1085953
- By:
- Publication type:
- Article
Commentary on the effects of receptor activator of nuclear factor‐B ligand inhibition on bone mass and muscle strength.
- Published in:
- Journal of Diabetes Investigation, 2020, v. 11, n. 2, p. 287, doi. 10.1111/jdi.13165
- By:
- Publication type:
- Article
Alendronate improves fasting plasma glucose and insulin sensitivity, and decreases insulin resistance in prediabetic osteopenic postmenopausal women: A randomized triple‐blind clinical trial.
- Published in:
- Journal of Diabetes Investigation, 2019, v. 10, n. 3, p. 731, doi. 10.1111/jdi.12944
- By:
- Publication type:
- Article
Atypical femoral fracture. A diagnostic challenge in glucocorticoid-induced osteoporosis.
- Published in:
- Clinical Cases in Mineral & Bone Metabolism, 2019, v. 16, n. 2, p. 150
- By:
- Publication type:
- Article
Atypical periprosthetic acetabular fracture in long-term alendronate therapy.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
Safety and effectiveness of teriparatide vs alendronate in postmenopausal osteoporosis: a prospective non randomized clinical study.
- Published in:
- Clinical Cases in Mineral & Bone Metabolism, 2016, v. 13, n. 3, p. 200
- By:
- Publication type:
- Article
Denosumab is really effective in the treatment of osteoporosis secondary to hypogonadism in prostate carcinoma patients? A prospective randomized multicenter international study.
- Published in:
- Clinical Cases in Mineral & Bone Metabolism, 2016, v. 13, n. 3, p. 195
- By:
- Publication type:
- Article
An atypical fracture in male patient with osteogenesis imperfecta.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
Bilateral atypical femoral subtrochanteric fractures in a premenopausal patient receiving prolonged bisphosphonate therapy: evidence of severely suppressed bone turnover.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
Normalization of bone mineral density after five years of treatment with strontium ranelate.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
Vγ9Vδ2 T lymphocytes activation in osteoporotic patients treated with bisphosphonates.
- Published in:
- Clinical Cases in Mineral & Bone Metabolism, 2014, v. 11, n. 2, p. 126
- By:
- Publication type:
- Article
Generic vs brand originator alendronate: analysis of persistence and compliance in five Local Healthcare Units in the Lombardy Region of Italy.
- Published in:
- Clinical Cases in Mineral & Bone Metabolism, 2013, v. 10, n. 3, p. 195
- By:
- Publication type:
- Article
A drinkable formulation of alendronate: potential to increase compliance and decrease upper GI irritation.
- Published in:
- Clinical Cases in Mineral & Bone Metabolism, 2013, v. 10, n. 3, p. 187
- By:
- Publication type:
- Article
When the FRAX® test is applied to controlled clinical trials.
- Published in:
- Clinical Cases in Mineral & Bone Metabolism, 2012, v. 9, n. 3, p. 135
- By:
- Publication type:
- Article
From the Editor-in-Chief.
- Published in:
- Clinical Cases in Mineral & Bone Metabolism, 2012, v. 9, n. 2, p. 69
- By:
- Publication type:
- Article
EFFICACY OF ALENDRONATE IN THE MANAGEMENT OF FRAGILITY FRACTURES.
- Published in:
- 2010
- By:
- Publication type:
- Abstract